You are here:
Research
![Click here to see enlarge photo of Fas/CD95 receptor clustering on living cells, and caption. Click here to see enlarge photo of Fas/CD95 receptor clustering on living cells, and caption.](https://webarchive.library.unt.edu/eot2008/20090114170741im_/http://www.niams.nih.gov/Research/Ongoing_Research/images/ab_images/irg_banner.jpg)
Immunoregulation Group
Richard Siegel, M.D., Ph.D.
Group Leader, Immunoregulation Group
Autoimmunity Branch (AB)
Phone: (301) 496-5767
Fax: (301) 480-3880
E-mail: siegelr@mail.nih.gov
Research Overview
The goal of the Immunoregulation Group is to understand how alterations in regulatory signaling pathways in immune cells lead to abnormal immune responses, chronic inflammation, and autoimmune diseases. The TNF family of cytokines is the main focus of present work, as these cytokines are critical in the pathogenesis and treatment of a number of different autoimmune and inflammatory diseases. We are particularly interested in how membrane-proximal events in receptor signal transduction can be influenced by environmental or other signals to alter cellular responses, since understanding these principles may aid in designing more effective therapeutic strategies to modulate the effects of TNF-receptor family signaling in autoimmune and inflammatory diseases. The general strategy of the lab is to better understand basic mechanisms of transmembrane signal transduction by selected TNF family receptors using the both cell and molecular biology approaches. We are also interested in studying the role of particular TNF family ligand-receptor systems in immune cells through mouse models. Recently, the lab has focused on three members of the TNF-receptor superfamily
- Fas and Fas Ligand: The Fas receptor has been shown to be important in immunoreceptor-mediated apoptosis of activated T and B lymphocytes. Both humans and mice with germ line mutations in the death receptor Fas accumulate abnormal lymphocytes and develop systemic autoimmunity. While most patients with non-familial autoimmune disease do not carry germ line Fas mutations, there is evidence that Fas-mediated apoptosis may be impaired in the milieu of chronic inflammation. We have been investigating what signals regulate Fas-mediated apoptosis in T cells, with the eventual aim of harnessing these discoveries to modulate Fas-induced apoptosis for therapeutic goals in human disease. We have recently identified the Rac family of small GTPases as critical regulators of Fas-induced apoptosis. We are also studying the regulation of FasL trafficking and function and are studying the role of the Wiskott-Aldrich Syndrome Protein (WASp) in this process
- TNF Receptor 1 (TNFR1). This receptor is critical for triggering inflammatory responses in myeloid cells of the immune system and other organ systems, and has been successfully targeted by biologic therapeutics in rheumatoid arthritis and other inflammatory diseases. We are working with the Genetics and Genomics Branch in NIAMS to understand the pathophysiology of inflammation in patients with the TNF Receptor Associated Periodic Syndrome (TRAPS) a genetic autoinflammatory disease associated with dominant mutations in TNFR1. We have recently discovered that TNFR1 mutant molecules associated with TRAPS are misfolded and accumulate in the endoplasmic reticulum. We are characterizing the mechanisms by which these mutant receptors lead to hyperactivity of the innate immune system.
- DR3: The function of this TNF-family receptor, highly related to TNFR1 but expressed mainly on lymphocytes has not been well characterized. We are investigating novel contributions of this receptor and its ligand, TL1A, to the pathophysiology of autoimmune diseases.
Selected Publications
Madhu Ramaswamy, Celine Dumont, Anthony C. Cruz, Jagan R. Muppidi, Timothy S. Gomez, Daniel D. Billadeau, Victor L.J. Tybulewicz, and Richard M. Siegel. (2007) Cutting Edge: Rac GTPases sensitize activated T cells to die via Fas. J. Immunol, in press.
Liu, E.H., Siegel, R.M., Harlan, D.M., and O'Shea, J.J. 2007. T cell-directed therapies: lessons learned and future prospects. Nat Immunol 8: 25-30.
Lobito, A.A., F.C. Kimberley, J.R. Muppidi, H. Komarow, A.J. Jackson, K.M. Hull, D.L. Kastner, G.R. Screaton, and R.M. Siegel. 2006. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood.108:1320-7.
Muppidi JR, Tschopp J, Siegel RM. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity. 2004; 21(4):461-5.
Muppidi JR, Siegel RM. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat Immunol. 2004; 5(2): 182-9.
See complete list of publications
Updated September 17, 2007